All In Biotech

Free tool

FAERS Monitor: Nicardipine Hydrochloride In 0.9% Sodium Chloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022276 or its brand name (Nicardipine Hydrochloride In 0.9% Sodium Chloride, Nicardipine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

4,421

Serious

4,266

96% of reports

Hospitalization

2,368

Death reported

591

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • acute kidney injury252
  • off label use216
  • premature baby209
  • drug ineffective198
  • foetal exposure during pregnancy198
  • maternal exposure during pregnancy187
  • hypotension175
  • drug interaction167
  • hypertension167
  • pyrexia123
  • premature delivery109
  • vomiting108
  • anaemia107
  • diarrhoea106
  • hyponatraemia105

Reports by year received

View as table
YearReports
200423
200515
2006108
200797
200858
200977
201054
201152
2012126
201397
2014105
2015140
2016159
2017248
2018358
2019288
2020235
2021313
2022385
2023390
2024410
2025451
2026231

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,738 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
premature babySignal20933.329.16,472
premature deliverySignal10932.827.23,306
foetal exposure during pregnancySignal19811.610.11,913
maternal exposure during pregnancySignal18710.08.71,509
hyponatraemiaSignal1058.97.4727
acute kidney injurySignal2527.87.01,507
drug interactionSignal1675.04.3536
hypotensionSignal1754.23.6419
hypertensionSignal1673.83.2338
anaemiaSignal1072.72.2111
pyrexia1231.71.435
off label use2161.21.06
vomiting1081.10.91
diarrhoea1060.80.66
drug ineffective1980.70.624

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.